YY1 and cancer: In contrast, YY1 is frequently overexpressed in most cancers [15], acting as an oncogene that promotes epithelial-mesenchymal transition (EMT) and metastasis [16], enhances cancer cell proliferation and survival [17], and sustains resistance to therapies [18].